Treatment patterns of aging americans with differentiated thyroid cancer

Cancer

Volumn 116, Issue 1, 2010, Pages 20-30

  Park, Henry S ^a   Roman, Sanziana A ^a   Sosa, Julie Ann ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiated thyroid cancer; Elderly; Practice guidelines; Radioactive iodine; Thyroidectomy

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; ASIAN AMERICAN; BIVARIATE ANALYSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DEMOGRAPHY; DIFFERENTIATED THYROID CANCER; EUROPEAN AMERICAN; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PACIFIC ISLANDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; UNITED STATES;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; COMBINED MODALITY THERAPY; ETHNIC GROUPS; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; SEX FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 74549186981     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24717     Document Type: Article

References (36)

1. United States Census Bureau. Available at: http://www.census.gov/ population/www/projections/downloadablefiles.html. Accessed May 2007.
2. McKenna RJS. Clinical aspects of cancer in the elderly: treatment decisions, treatment choices, and follow-up. Cancer. 1994;74:2107-2117.
3. Etzioni DA, Liu JH, Maggard MA, O'Connell JB, Ko CY. Workload projections for surgical oncology: will we need more surgeons? Ann Surg Oncol. 2003;10:1112-1117.
4. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
5. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
6. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154:1838-1840.
7. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93:363-369.
8. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142.
9. National Cancer Institute, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence-SEER 17 Regs Public-Use, 2005 Sub (1973-2005). Available at: http://www.seer.cancer.gov/ registries. Accessed August 2008.
10. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Staging Manual. 6th ed. New York, NY: Springer-Verlag, 2002.
11. Udelsman R, Lakatos E, Ladenson P. Optimal surgery for papillary thyroid carcinoma. World J Surg. 1996;20:88-93.
12. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at 1 institution during 1940 through 1989. Surgery. 1993;114:1050-1057; discussion 1057-1058.
13. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg. 1994;18:123-130.
14. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511-518.
15. Maxon HR 3rd, Englaro EE, Thomas SR, et al. Radioiodine-131 therapy for well-differentiated thyroid cancer - a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med. 1992;33:1132-1136.
16. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:1433-1441.
17. Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract. 2001;7:202-220.
18. Sherman SI, Angelos P, Ball DW, et al. Thyroid carcinoma. J Natl Compr Canc Netw. 2007;5:568-621.
19. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the mayo clinic during 6 decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879-885.
20. Rouxel A, Hejblum G, Bernier MO, et al. Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2004;89:5362-5368.
21. van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992;112:1130-1136; discussion 1136-1138.
22. Falvo L, Catania A, Sorrenti S, et al. Prognostic significance of the age factor in the thyroid cancer: statistical analysis. J Surg Oncol. 2004;88:217-222.
23. Bliss R, Patel N, Guinea A, Reeve TS, Delbridge L. Age is no contraindication to thyroid surgery. Age Ageing. 1999;28:363-366.
24. Casara D, Rubello D, Saladini G, De Besi P, Fassina A, Busnardo B. Differentiated thyroid carcinoma in the elderly. Aging (Milano). 1992;4:333-339.
25. Passler C, Avanessian R, Kaczirek K, Prager G, Scheuba C, Niederle B. Thyroid surgery in the geriatric patient. Arch Surg. 2002;137:1243-1248.
26. Sosa JA, Mehta PJ, Wang TS, Boudourakis L, Roman SA. A population-based study of outcomes from thyroidectomy in aging Americans: at what cost? J Am Coll Surg. 2008; 206:1097-1105.
27. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228:320-330.
28. Coburn MC, Wanebo HJ. Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg. 1995;170:471-475.
29. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer. 1997;80:1273-1283.
30. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35:181-200.
31. Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643-2650.
32. August DA, Rea T, Sondak VK. Age-related differences in breast cancer treatment. Ann Surg Oncol. 1994;1:45-52.
33. Ayanian JZ, Guadagnoli E. Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat. 1996;40:65-74.
34. Ahmed A, Zamba G, DeGeest K, Lynch CF. The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002. Gynecol Oncol. 2008;111:35-40.
35. Coburn MC, Pricolo VE, Soderberg CH. Factors affecting prognosis and management of carcinoma of the colon and rectum in patients more than eighty years of age. J Am Coll Surg. 1994;179:65-69.
36. Kunisaki C, Akiyama H, Nomura M, et al. Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients. Am J Surg. 2006;191:216-224.